Elena Luison
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 14
- Radiopharmaceutical Chemistry and Applications 8
- Oncology 8
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Silvana CanevariMariangela FiginiDelia MezzanzanicaMarina BagnoliEttore SeregniEmilio BombardieriAngela ColivaRenata Ferri
- Journals
- Cancer Immunology Immunotherapy (4 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)Biomedicines (1 paper)
- Partner nations
- ItalyGermanySwitzerland
In The Last Decade
Elena Luison
21 papers receiving 518 citations
Peers
Comparison fields: 5 of 64
- Radiology, Nuclear Medicine and Imaging 224
- Oncology 166
- Reproductive Medicine 43
- Immunology 107
- Biomaterials 48
Countries citing papers authored by Elena Luison
This map shows the geographic impact of Elena Luison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Luison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Luison more than expected).
Fields of papers citing papers by Elena Luison
This network shows the impact of papers produced by Elena Luison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Luison. The network helps show where Elena Luison may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elena Luison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2021 | 0 | |
| 3 | 2019 | 15 | |
| 4 | 2016 | 17 | |
| 5 | 2015 | 10 | |
| 6 | 2015 | 15 | |
| 7 | 2014 | 27 | |
| 8 | 2013 | 46 | |
| 9 | 2011 | 35 | |
| 10 | 2011 | 14 | |
| 11 | 2009 | 23 | |
| 12 | 2008 | 19 | |
| 13 | 2007 | 20 | |
| 14 | 2005 | 29 | |
| 15 | 2003 | 55 | |
| 16 | 2001 | 8 | |
| 17 | The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier molecule. | 2001 | 12 |
| 18 | 2000 | 6 | |
| 19 | Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody. | 1998 | 53 |
| 20 | Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. | 1997 | 39 |
About Elena Luison
Elena Luison is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Toxicology, Immunology and Allergy and Immunology, having authored 22 papers that have together received 532 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Glycosylation and Glycoproteins Research (4 papers), Prostate Cancer Treatment and Research (4 papers), Immunotherapy and Immune Responses (3 papers), HER2/EGFR in Cancer Research (3 papers), Cell death mechanisms and regulation (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (224 citations), Oncology (166 citations), Reproductive Medicine (43 citations), Immunology (107 citations) and Biomaterials (48 citations). Elena Luison has collaborated with scholars based in Italy, Germany and Switzerland. Frequent co-authors include Silvana Canevari, Mariangela Figini, Delia Mezzanzanica, Marina Bagnoli, Ettore Seregni, Emilio Bombardieri, Angela Coliva, Renata Ferri, Mario P. Colombo and Giovanni Paganelli. Their work appears in journals such as Cancer Immunology Immunotherapy, Molecular Cancer Therapeutics, Clinical Cancer Research, European Journal of Cancer and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.